Tagoor Laboratories Pvt Ltd

Established in 2018, Tagoor Laboratories is a trusted, preferred partner to customers in supplying advanced intermediates, key starting materials, APIs and CDMO services, operating four manufacturing facilities, with the fourth dedicated to oncology. The company has received CEPs for Pantoprazole, Loratadine and Thioctic Acid, and filed CEPs for Rupatadine and Terbinafine, with major products including Pantoprazole, Domperidone, Esomeprazole, Omeprazole, Loratadine, Vildagliptin and their intermediates, and has developed new products such as Resmetirom, Mavacamten and Tegoprazan.